Fluconazole in the treatment of Cushing's disease

Abstract

UNLABELLED Ketoconazole was a first-line agent for suppressing steroidogenesis in Cushing's disease. It now has limited availability. Fluconazole, another azole antifungal, is an alternative, although its in vivo efficacy is unclear. A 61-year-old female presented with weight gain, abdominal striae and worsening depression. HbA1c increased to 76 mmol/mol… (More)
DOI: 10.1530/EDM-15-0115

Topics

2 Figures and Tables

Slides referencing similar topics